Wegovy (semaglutide) now has Medicare approval for coverage among people with obesity and cardiovascular disease but no diabetes; a study looks at what level of risk might make someone eligible.

An expert on pain management discusses why relying on medications to ease discomfort can easily backfire, and how people can avoid complete reliance on these types of drugs.

The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.

GLP1RA drugs are used to treat obesity as well as type 2 diabetes. Research from University of Michigan Health finds that these drugs can also be effective in treating high iron levels, a cause and symptom of type 2 diabetes.

Alice Tapper, daughter of CNN anchor Jake Tapper, has released a children’s book, “Use Your Voice”, with proceeds benefiting Michigan Medicine.

Older adults face a higher risk of severe COVID-19, but an updated vaccine offers additional protection. A new poll shows which people over 50 are most likely to get it.

People having heart surgery to repair leaking mitral or tricuspid valves may receive a pacemaker more often than necessary — leading to a greater risk for life threatening complications.

Patients at the University of Michigan Health C.S. Mott Children's Hospital celebrated a gift from Hyundai Hope On Wheels.

Michigan Medicine announces new leader for academic medical center of the University of Michigan

After undergoing brain surgery as a child, Glenn Ratledge is now working as the ball boy for the Detroit Pistons and has been seizure free for 13 years.

A urologic oncologist answers questions about prostate cancer.

Michigan Medicine will launch a new era in comprehensive breast cancer care, thanks to a generous donation from the Weiser Charitable Foundation.

Researchers have developed a new model to help predict treatment response in patients with bladder cancer. 

A study shows that disulfiram, known for causing severe hangover symptoms by blocking alcohol breakdown, also inhibits the inflammatory NLRP3 complex.

Research suggests that one day a phone app could be able to detect the development of hepatic encephalopathy in patients just by listening to them speak.